- Report
- March 2025
- 120 Pages
Global
From €4329EUR$4,900USD£3,793GBP
- Report
- March 2025
- 115 Pages
Global
From €4329EUR$4,900USD£3,793GBP
- Report
- February 2025
- 287 Pages
Global
From €4859EUR$5,500USD£4,257GBP
- Report
- February 2025
Global
From €4329EUR$4,900USD£3,793GBP
- Report
- October 2025
- 120 Pages
Global
From €5256EUR$5,950USD£4,605GBP
- Report
- October 2025
- 148 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- September 2025
- 142 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- September 2025
- 147 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- September 2025
- 139 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- August 2025
- 139 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- August 2025
- 149 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- August 2025
- 143 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- August 2025
- 136 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- August 2025
- 147 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- August 2025
- 145 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- May 2025
- 149 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- May 2025
- 144 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- May 2025
- 137 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- March 2025
- 142 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- March 2025
- 141 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more